Recent Posts
- New Study Explores Nalmefene and Naloxone for Reversal of Respiratory Depression Induced by Fentanyl in a Clinical Opioid Induced Respiratory Depression Model
- Study Examining Use of Nalmefene HCI Injection for Opioid Overdose Reversal in Emergency Departments Concludes Observational Period
- FDA Approves Zurnai™ (nalmefene injection) Auto-Injector for the Emergency Treatment of Known or Suspected Opioid Overdose Induced by Natural or Synthetic Opioids in Adults and Pediatric Patients 12 Years and Older
- Purdue Pharma L.P. Enters Agreement to Provide Low-Cost Opioid Use Disorder Treatment to Correctional Facilities for Incarcerated Individuals
- FDA Accepts Filing of New Drug Application for Nalmefene Auto-injector for the Treatment of Known or Suspected Opioid Overdose
Archives
- October 2024
- September 2024
- August 2024
- May 2024
- April 2024
- March 2024
- December 2023
- August 2023
- May 2023
- March 2023
- January 2023
- November 2022
- June 2022
- March 2022
- February 2022
- December 2021
- September 2021
- July 2021
- June 2021
- March 2021
- October 2020
- August 2020
- June 2020
- March 2020
- February 2020
- September 2019
- August 2019
- July 2019
- June 2019
- April 2019
- March 2019
- February 2019
- January 2019
- October 2018
- September 2018
- August 2018
- February 2018
- January 2018